2-(pyrazin-2-yl)benzaldehyde

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(pyrazin-2-yl)benzaldehyde
• 英文别名: 2-Pyrazin-2-ylbenzaldehyde
• 化学式: C₁₁H₈N₂O
• 分子量: 184.197
• InChiKey: GXUCYDMIWVZAPL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(pyrazin-2-yl)benzaldehyde 、 硼氢化钠 在 氮 、 氯化铵 、 乙酸乙酯 、 水 、 Brine 、 magnesium sulfate 、 Silica gel 作用下， 以 甲醇 为溶剂， 反应 2.0h， 以Silica gel chromatography (70% EtOAc-hexanes) afforded the title compound as a pale red-brown oil的产率得到
  参考文献：
  名称：

  Thrombin inhibitors

  摘要：

  本发明的化合物在抑制凝血酶和相关的血栓闭塞方面非常有用，具有以下结构式（I）：其中u为CH或N；Q为1）-N（R25）CH（R30）-，其中氮原子连接到R1，而R25和R30分别选自氢，C3-6环烷基和C1-6烷基的组成群，或2）其中氮原子连接到R1，且m为0、1或2。

  公开号：

  US07144899B2
• 作为产物：
  描述：

  2-氯吡嗪 、 2-羟甲基苯硼酸 在 C₄₆H₄₉BrClFeN₃Pd 、 copper diacetate 、 caesium carbonate 作用下， 以 1,4-二氧六环 为溶剂， 反应 24.0h， 以78%的产率得到2-(pyrazin-2-yl)benzaldehyde
  参考文献：
  名称：

  Synthesis, crystal structures and catalytic activity of three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with N -heterocyclic carbenes (NHCs) and triphenylphosphine

  摘要：

  Three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with NHCs and PPh3 1-3 have been synthesized and characterized by elemental analysis, IR, NMR and single-crystal X-ray diffraction. Their application to Suzuki coupling of phenylboronic acid containing hydroxymethyl was also investigated. An efficient 3/Cu cocatalyzed oxidation/Suzuki coupling of aryl chlorides with phenylboronic acids containing hydroxymethyl in air has been developed. (C) 2014 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.ica.2014.07.037

文献信息

• US7144899B2
  申请人：——

  公开号：US7144899B2

  公开（公告）日：2006-12-05
• [EN] THROMBIN INHIBITORS<br/>[FR] INHIBITEURS DE THROMBINE
  申请人：MERCK & CO INC

  公开号：WO2002064559A2

  公开（公告）日：2002-08-22

  Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure Formula (I): wherein u is CH or N; Q is 1)-N(R?25)CH(R30¿)- wherein the nitrogen atom is attached to R?1, and R25 and R30¿ are independently selected from the group consisting of hydrogen, C¿3-6?cycloalkyl, and C1-6alkyl, or 2) wherein the nitrogen atom is attached to R?1¿, and m is 0, 1, or 2.
• [EN] FUSED HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS D'HÉTÉROARYLE FUSIONNÉS UTILISÉS COMME ANTAGONISTES DE RÉCEPTEURS DE L'OREXINE
  申请人：MERCK SHARP & DOHME

  公开号：WO2016106106A2

  公开（公告）日：2016-06-30

  The present invention is directed to fused heteroaryl derivative compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.